(SGMO) Sangamo Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Sangamo Therapeutics | (SGMO) share price targets
Complete technical analysis of Sangamo Therapeutics (SGMO) by charts plus indicators, forecast predictions and share price targets for Sangamo Therapeutics (SGMO)
Sangamo Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-01-17 View latest technical analysis
10 day averaged volume of Sangamo Therapeutics is 6286660
| Date | Daily Closing Price | Open | High | Low | Volume |
| 17 Fri Jan 2025 | 1.09 | 1.10 | 1.14 | 1.08 | 0.689 times |
| 17 Fri Jan 2025 | 1.09 | 1.10 | 1.14 | 1.08 | 0.689 times |
| 16 Thu Jan 2025 | 1.10 | 1.12 | 1.14 | 1.06 | 0.681 times |
| 15 Wed Jan 2025 | 1.10 | 1.08 | 1.14 | 1.05 | 1.187 times |
| 14 Tue Jan 2025 | 1.03 | 1.12 | 1.18 | 1.00 | 0.746 times |
| 13 Mon Jan 2025 | 1.08 | 1.12 | 1.15 | 1.03 | 1.071 times |
| 10 Fri Jan 2025 | 1.17 | 1.23 | 1.25 | 1.12 | 0.821 times |
| 08 Wed Jan 2025 | 1.22 | 1.35 | 1.37 | 1.20 | 0.955 times |
| 08 Wed Jan 2025 | 1.22 | 1.35 | 1.37 | 1.20 | 0.955 times |
| 07 Tue Jan 2025 | 1.37 | 1.37 | 1.51 | 1.34 | 1.16 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 0.9 as stoploss in an intra day buy trade for a target of 1.56. However, stock will show a bearish move below 0.9.
Share price targets for Sangamo Therapeutics (SGMO)
| Target Type | Value |
| Downside Target | 0.70 |
| Downside Target | 0.74 |
| Downside Target | 0.91 |
| Downside Target | 0.97 |
| Downside Target | 1.00 |
| Downside Target | 1.08 |
| Upside Target | 1.12 |
| Upside Target | 1.18 |
| Upside Target | 1.37 |
| Upside Target | 1.51 |
| Upside Target | 1.72 |
| Upside Target | 2.30 |
| Upside Target | 2.50 |
| Upside Target | 2.84 |
| Upside Target | 3.18 |
Intraday share price targets for Sangamo Therapeutics (SGMO)
| Target Type | Value |
| Downside Intraday Target | 1.07 |
| Downside Intraday Target | 1.04 |
| Upside Intraday Target | 1.13 |
| Upside Intraday Target | 1.16 |
| Upside Intraday Target | 1.1 |
Weekly technical analysis of Sangamo Therapeutics (SGMO)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 17 Fri Jan 2025 | 1.09 | 1.10 | 1.14 | 1.08 | 0.158 times |
| 17 Fri Jan 2025 | 1.09 | 1.12 | 1.18 | 1.00 | 2.462 times |
| 10 Fri Jan 2025 | 1.17 | 1.35 | 1.37 | 1.12 | 0.461 times |
| 08 Wed Jan 2025 | 1.22 | 1.35 | 1.51 | 1.20 | 0.314 times |
| 03 Fri Jan 2025 | 1.30 | 2.49 | 2.50 | 0.91 | 4.664 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Sangamo Therapeutics (SGMO)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 17 Fri Jan 2025 | 1.09 | 1.02 | 1.51 | 0.97 | 0.588 times |
| 31 Tue Dec 2024 | 1.02 | 2.02 | 2.84 | 0.91 | 0.99 times |
| 26 Tue Nov 2024 | 2.14 | 1.78 | 3.18 | 1.72 | 0.683 times |
| 31 Thu Oct 2024 | 1.70 | 0.86 | 2.30 | 0.74 | 3.487 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Sangamo Therapeutics (SGMO)
Price action analysis of Sangamo Therapeutics ( (SGMO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Sangamo Therapeutics ( (SGMO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Sangamo Therapeutics ( (SGMO) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Sangamo Therapeutics ( (SGMO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Sangamo Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Sangamo Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Sangamo Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sangamo Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Sangamo Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.16 and Sangamo Therapeutics (SGMO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sangamo Therapeutics (SGMO) stock. Volume based technical analysis of Sangamo Therapeutics (SGMO) stock is negative.
Sangamo Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Sangamo Therapeutics ( (SGMO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Sangamo Therapeutics ( (SGMO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Sangamo Therapeutics ( (SGMO) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Sangamo Therapeutics ( (SGMO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Sangamo Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Sangamo Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Sangamo Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sangamo Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Sangamo Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.16 and Sangamo Therapeutics (SGMO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sangamo Therapeutics (SGMO) stock. Volume based technical analysis of Sangamo Therapeutics (SGMO) stock is negative.
Sangamo Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.